243 related articles for article (PubMed ID: 27253373)
21. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
[TBL] [Abstract][Full Text] [Related]
22. Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.
Zhou J; Wang J; Zeng Y; Zhang X; Hu Q; Zheng J; Chen B; Xie B; Zhang WM
Oncotarget; 2015 Dec; 6(42):44332-45. PubMed ID: 26554308
[TBL] [Abstract][Full Text] [Related]
23. Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer.
Wang C; Wang L; Su B; Lu N; Song J; Yang X; Fu W; Tan W; Han B
Prostate; 2014 May; 74(7):689-701. PubMed ID: 24619958
[TBL] [Abstract][Full Text] [Related]
24. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression.
Huang R; Zong X
Crit Rev Oncol Hematol; 2017 Jul; 115():13-22. PubMed ID: 28602165
[TBL] [Abstract][Full Text] [Related]
25. Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway.
Elghonaimy EA; Ibrahim SA; Youns A; Hussein Z; Nouh MA; El-Mamlouk T; El-Shinawi M; Mostafa Mohamed M
Tumour Biol; 2016 Sep; 37(9):12441-12453. PubMed ID: 27329104
[TBL] [Abstract][Full Text] [Related]
26. Galectin-8 induces partial epithelial-mesenchymal transition with invasive tumorigenic capabilities involving a FAK/EGFR/proteasome pathway in Madin-Darby canine kidney cells.
Oyanadel C; Holmes C; Pardo E; Retamal C; Shaughnessy R; Smith P; Cortés P; Bravo-Zehnder M; Metz C; Feuerhake T; Romero D; Roa JC; Montecinos V; Soza A; González A
Mol Biol Cell; 2018 Mar; 29(5):557-574. PubMed ID: 29298841
[TBL] [Abstract][Full Text] [Related]
27. miR-29b regulates Ang II-induced EMT of rat renal tubular epithelial cells via targeting PI3K/AKT signaling pathway.
Hu H; Hu S; Xu S; Gao Y; Zeng F; Shui H
Int J Mol Med; 2018 Jul; 42(1):453-460. PubMed ID: 29568897
[TBL] [Abstract][Full Text] [Related]
28. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
[TBL] [Abstract][Full Text] [Related]
29. Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer.
Karvelsson ST; Wang Q; Hilmarsdottir B; Sigurdsson A; Moestue SA; Mælandsmo GM; Halldorsson S; Gudmundsson S; Rolfsson O
NPJ Syst Biol Appl; 2021 Sep; 7(1):36. PubMed ID: 34535676
[TBL] [Abstract][Full Text] [Related]
30. Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.
Cursons J; Leuchowius KJ; Waltham M; Tomaskovic-Crook E; Foroutan M; Bracken CP; Redfern A; Crampin EJ; Street I; Davis MJ; Thompson EW
Cell Commun Signal; 2015 May; 13():26. PubMed ID: 25975820
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition.
Tian B; Li X; Kalita M; Widen SG; Yang J; Bhavnani SK; Dang B; Kudlicki A; Sinha M; Kong F; Wood TG; Luxon BA; Brasier AR
BMC Genomics; 2015 Jul; 16(1):529. PubMed ID: 26187636
[TBL] [Abstract][Full Text] [Related]
32. The P2RY2 Receptor Induces Carcinoma Cell Migration and EMT Through Cross-Talk With Epidermal Growth Factor Receptor.
Martínez-Ramírez AS; Garay E; García-Carrancá A; Vázquez-Cuevas FG
J Cell Biochem; 2016 Apr; 117(4):1016-26. PubMed ID: 26443721
[TBL] [Abstract][Full Text] [Related]
33. Application of 3D Culture Assays to Study Breast Morphogenesis, Epithelial Plasticity, and Cellular Interactions in an Epithelial Progenitor Cell Line.
Sigurdardottir AK; Hilmarsdottir B; Gudjonsson T; Traustadottir GA
Methods Mol Biol; 2022; 2429():391-403. PubMed ID: 35507176
[TBL] [Abstract][Full Text] [Related]
34. Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.
Fuchs BC; Fujii T; Dorfman JD; Goodwin JM; Zhu AX; Lanuti M; Tanabe KK
Cancer Res; 2008 Apr; 68(7):2391-9. PubMed ID: 18381447
[TBL] [Abstract][Full Text] [Related]
35. Silencing of angiotensin II type-1 receptor inhibits high glucose-induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells via inactivation of mTOR/p70S6K signaling pathway.
Gong Q; Hou F
Biochem Biophys Res Commun; 2016 Jan; 469(2):183-8. PubMed ID: 26626074
[TBL] [Abstract][Full Text] [Related]
36. Multi-walled carbon nanotubes directly induce epithelial-mesenchymal transition in human bronchial epithelial cells via the TGF-β-mediated Akt/GSK-3β/SNAIL-1 signalling pathway.
Polimeni M; Gulino GR; Gazzano E; Kopecka J; Marucco A; Fenoglio I; Cesano F; Campagnolo L; Magrini A; Pietroiusti A; Ghigo D; Aldieri E
Part Fibre Toxicol; 2016 Jun; 13(1):27. PubMed ID: 27251132
[TBL] [Abstract][Full Text] [Related]
37. Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines.
Kondaveeti Y; Guttilla Reed IK; White BA
Cancer Lett; 2015 Aug; 364(1):44-58. PubMed ID: 25917568
[TBL] [Abstract][Full Text] [Related]
38. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
[TBL] [Abstract][Full Text] [Related]
39. Gefitinib resistance of cancer cells correlated with TM4SF5-mediated epithelial-mesenchymal transition.
Lee MS; Kim HP; Kim TY; Lee JW
Biochim Biophys Acta; 2012 Feb; 1823(2):514-23. PubMed ID: 22178131
[TBL] [Abstract][Full Text] [Related]
40. Comparative gene co-expression network analysis of epithelial to mesenchymal transition reveals lung cancer progression stages.
Wang D; Haley JD; Thompson P
BMC Cancer; 2017 Dec; 17(1):830. PubMed ID: 29212455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]